RN7SL444P

Across TCGA pan-cancer cohorts, RN7SL444P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RN7SL444P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RN7SL444P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL444P is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

BLCA, HNSC, and KICH are the cancer types where RN7SL444P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL444P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	All	+0.513	.001	6	view →
HNSC	Male	All	+0.160	.002	6	view →
KICH	Female	II,III,IV	−0.378	<.001	4	view →
CHOL	All	All	+0.453	.019	3	view →
KIRC	All	II,III,IV	+0.109	.025	3	view →
LIHC	Male	All	+0.102	.008	3	view →
PAAD	Male	All	+0.515	.026	2	view →
KIRP	All	All	−0.189	.013	2	view →
BRCA	All	All	+0.135	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RN7SL444P–BLCA

Open the BLCA breakdown →